Cesar Freytes, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Cesar Freytes is an Oncology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 240 publications with 8,759 citations (h-index 55); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7700 Floyd Curl Dr
San Antonio, TX 782293902
Telephone
210-575-3817Registry record last updated 3 Jan 2018.
Clinical trials
- Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation
Sponsor: The University of Texas Health Science Center at San Antonio
- Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Sponsor: The University of Texas Health Science Center at San Antonio
- Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Sponsor: The University of Texas Health Science Center at San Antonio
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20241 payment
- Pharming Healthcare, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2005–2006 per NIH RePORTER. The latest:
- EVAL CHNGS IN CYTOKINES W CHGS IN CLIN STG; MYELOMA BONE DIS IN PTS W MULT MYEL
University of Texas Hlth Science Center
FY2006$51,288M01RR001346 - EVAL CHNG IN CYTOKINES W CHNG IN CLIN STG AND MYELOMA BONE DIS IN PTS W MUL MYEL
University of Texas Hlth Sci Ctr San Ant
FY2005$119,333M01RR001346
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy
British Journal of Haematology
2020 - Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis
Biology of Blood and Marrow Transplantation
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”